Related Experiment Video
Updated: Oct 6, 2025

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
Published on: January 16, 2015
Dysregulated Cell Signaling in Pulmonary Emphysema
Chih-Ru Lin1,2, Karim Bahmed2,3, Beata Kosmider1,2
1Department of Microbiology, Immunology, and Inflammation, Temple University, Philadelphia, PA, United States.
Pulmonary emphysema, driven by smoking, involves alveolar wall destruction and airflow limitation. This review details signaling pathway dysregulation, particularly in alveolar type II cells, and discusses potential treatments.
Area of Science:
- Pulmonary Medicine
- Cell Biology
- Pathophysiology
Background:
- Pulmonary emphysema involves alveolar septa destruction and irreversible airflow limitation, primarily caused by cigarette smoking.
- Alveolar type II (ATII) cells, crucial for lung repair, exhibit dysfunction in emphysema, a disease lacking effective treatments.
- Emphysema pathogenesis is complex, involving disrupted signaling pathways, oxidative stress, inflammation, and genetic factors.
Purpose of the Study:
- To comprehensively review studies on dysregulated cell signaling in emphysema, focusing on ATII cells.
- To elucidate the contribution of these signaling pathways to alveolar wall destruction.
- To describe relevant preclinical and clinical interventions for emphysema.
Main Methods:
- Literature review of studies on emphysema pathophysiology and cell signaling.
- Analysis of research on alveolar type II cell function and dysfunction.
- Compilation of data on preclinical and clinical interventions.
Main Results:
- Emphysema is linked to dysregulated signaling pathways, including inflammation, oxidative stress, and proteostasis.
- ATII cell dysfunction significantly contributes to alveolar wall destruction in emphysema.
- Various signaling pathways implicated in emphysema progression are identified.
Conclusions:
- Understanding dysregulated cell signaling in ATII cells is crucial for emphysema research.
- Targeting specific signaling pathways offers potential therapeutic strategies for emphysema.
- Further research into cellular mechanisms and interventions is needed for effective emphysema treatment.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...

